• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Cassava Sciences

Darts failing to hit bullseye
Biotech

2025's top 10 clinical trial flops

Fierce Biotech looks back at 10 of the most impactful and interesting clinical failures of 2025.
James Waldron , Nick Paul Taylor Feb 9, 2026 3:00am
Paragliding over the cliffs Fort Funston San Francisco

Altos ascends with new clinical leader—Chutes & Ladders

Aug 8, 2025 8:30am
Parachute over a mountain in Switzerland

Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders

Apr 25, 2025 8:30am
Cartoon of businessmen standing around a broken target

Cassava stops Alzheimer's program as simufilam fails again

Mar 25, 2025 9:12am
Graphic showing arrows missing the bullseye on a target

2024's top 10 clinical trial flops

Feb 18, 2025 3:00am
workers

Cassava cuts 3rd of staff in wake of phase 3 Alzheimer's fail

Jan 8, 2025 3:38am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings